1)Bruera E, Moyano J, Seifert L, et al:The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage 10:599-603, 1995
2)Bruera E, Paice JA:Cancer Pain Management:Safe and Effective Use of Opioids. In:2015 ASCO Educational Book. American Society of Clinical Oncology, Alexandria, e593-e599, 2015
3)Del Fabbro E:Assessment and management of chemical coping in patients with cancer. J Clin Oncol 32:1734-1738, 2014
4)権 哲,細川豊史:【がん患者のココロを支える】痛みを訴えるがん患者への“ケミカルコーピング”ケミカルコーピングとオピオイド依存・乱用の評価とその対応(解説/特集).薬局 68:2814-2819, 2017
5)廣瀬宗孝,田畑麻里,坂井美賀子:慢性非がん性痛患者における長期オピオイド療法による依存と嗜癖(総説).日本ペインクリニック学会誌 18:25-33, 2011
6)Højsted J, Sjøgren P:Addiction to opioids in chronic pain patients:a literature review. Euro J Pain 11:490-495, 2007
7)Khantzian EJ:The self-medication hypothesis of substance use disorders:a reconsideration and recent applications. Harv Rev Psychiatry 4:231-244, 1997
8)Kirsh KL, Jass C, Bennett DS, et al:Initial development of a survey tool to detect issues of chemical coping in chronic pain patients. Palliat Support Care 5:219-226, 2007
9)国立がん研究センターがん対策情報センター:全国がん罹患モニタリング集計2006-2008年生存率報告.https://ganjoho.jp/data/reg_stat/statistics/brochure/mcij2006-2008_report.pdf, 2016
10)Koyyalagunta D, Bruera E, Aigner C, et al:Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF. Pain Med 14:667-675, 2013
11)Kwon JH, Tanco K, Hui D, et al:Chemical coping versus pseudoaddiction in patients with cancer pain. Palliat Support Care 12:413-417, 2014
12)Lawlor P, Walker P, Bruera E, et al:Severe opioid toxicity and somatizationof psychosocial distress in a cancer patient with a background of chemical dependence. J Pain Symptom Manage 13:356-361, 1997
13)Mehnert A, Koch U:Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors. J Psychosomat Res 64:383-391, 2008
14)Moulin DE, Iezzi A, Amireh R, et al:Randomised trial of oral morphine for chronic non-cancer pain. Lancet 347:143-147, 1996
15)日本ペインクリニック学会 非がん慢性疼痛に対するオピオイド鎮痛薬処方ガイドライン作成ワーキンググループ編:非がん性慢性疼痛にたいするオピオイド鎮痛薬処方ガイドライン.真興交易医書出版部,p48, 2012
16)Parsons HA, Delgado-Guay MO, El Osta B, et al:Alcoholism screening in patients with advanced cancer:impact on symptom burden and opioid use. J Palliat Med 11:964-968, 2008
17)Savage SR, Joranson DE, Covington EC, et al:Definitions related to the medical use of opioids:evolution towards universal agreement. J Pain Symptom Manage 26:655-667, 2003
18)高木雄亮,有賀悦子:【がん患者のココロを支える】痛みを訴えるがん患者への”ケミカルコーピング”がん疼痛とケミカルコーピングの考え方(解説/特集).薬局 68:2807-2812, 2017
19)Weissman DE, Haddox JD:Opioid pseudoaddiction-an iatrogenic syndrome. Pain 36:363-366, 1989
20)Wu SM, Compton P, Bolus R, et al:The addiction behaviors checklist:validation of a new clinician-based measure of inappropriate opioid use in chronic pain. J Pain Symptom Manage 32:342-351, 2006
21)山口重樹:ケミカルコーピングと偽依存 疑いの目を持ちつつも寄り添う気持ちが,嗜癖(精神依存)から患者を救う.医学界新聞,第3244号,2017 http://www.igaku-shoin.co.jp/paperDetail.do?id=PA03244_02